Skip to search.
 TSX Down 0.00% TSX Ventures Up 0.75%

Abbott Laboratories (ABT)

-NYSE
47.56 Up 0.07(0.15%) 3:57PM EDT - NYSE Real Time Price
Add to Portfolio
Prev Close:47.49
Open:47.62
Bid:47.61 x 3600
Ask:47.62 x 2300
1y Target Est:50.09
Beta:1.06
Earnings Date:Jul 14 - Jul 20 (Est.)
Day's Range:47.01 - 47.73
52wk Range:38.25 - 48.62
Volume:3,034,725
Avg Vol (3m):5,458,580
Market Cap:71.77B
P/E (ttm):17.21
EPS (ttm):2.76
Div & Yield:0.96 (2.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTUp 0.15%71.77B
NSRGYUp 0.05%N/A
RHHBYDown 1.13%N/A
TEVADown 0.49%52.25B

Key Statistics

Forward P/E (1 yr):19.84
P/S (ttm):3.51
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :2.16
Quarterly EPS Est (Jun-15) :0.50
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback